Corrigendum to "Nargenicin A1 attenuates lipopolysaccharide-induced inflammatory and oxidative response by blocking the NF-κB signaling pathway" [EXCLI Journal 2021;20:968-982]

Authors

DOI:

https://doi.org/10.17179/excli2025-8358

Keywords:

corrigendum, nargenicin A1, inflammation, ROS, NF-κB

Additional Files

Published

2025-03-24

How to Cite

Kwon, D. H., Kim, G.-Y., Cha, H.-J., Kim, S., Kim, H.-S., Hwang, H.-J., & Choi, Y. H. (2025). Corrigendum to "Nargenicin A1 attenuates lipopolysaccharide-induced inflammatory and oxidative response by blocking the NF-κB signaling pathway" [EXCLI Journal 2021;20:968-982]. EXCLI Journal, 24, 452–453. https://doi.org/10.17179/excli2025-8358

Issue

Section

Corrigenda

Most read articles by the same author(s)